📅Offer Date: 14 Jul 2025 – 16 Jul 2025
Data sourced from BSE & NSE · Last updated
Anthem Biosciences Limited IPO was subscribed 63.85x in total when bidding closed on 16 Jul 2025, with 182.65x in the QIB category, 42.35x in NII, 5.61x in retail. The issue ran from 14 Jul 2025 to 16 Jul 2025 at a price band of ₹540.00–₹570.00 per share.
Times subscribed by category against the 1× line.
Based on retail subscription (5.61x). Final allotment decided by registrar's computerised lottery.
| Category | Offer | Applied | Times |
|---|---|---|---|
| QIBs | 2,97,08,333 | 5,42,62,27,022 | 182.65x |
| NIIs | 89,12,500 | 37,74,44,375 | 42.35x |
| SNIIs (<10L) | 29,70,833 | 8,66,59,199 | 29.17x |
| BNIIs (>10L) | 59,41,667 | 29,07,85,183 | 48.94x |
| Retail | 2,07,95,833 | 11,66,64,623 | 5.61x |
| Total | 4,17,50,321 | 2,66,57,57,996 | 63.85x |
| Category | Offered | Demand | Times |
|---|---|---|---|
| QIBs | 1693.37 | 309294.94 | 182.65x |
| NIIs | 508.01 | 21514.33 | 42.35x |
| Retail | 1185.36 | 6649.88 | 5.61x |
| Total | 3386.75 | 337459.15 | 63.85x |
Values derived from share count × issue price (₹570.00)
Because Anthem Biosciences Limited closed oversubscribed, allotment follows the applicable category and exchange rules. A high subscription figure reflects strong demand but does not guarantee a premium listing, and a low figure does not guarantee a discount. This page is for information only and is not investment advice.
BSE, NSE listed · Bidding data sourced from BSE & NSE under SEBI ICDR regulations.